Patients suffering from AIDS (acquired immune deficiency syndrome) are at risk of developing significant ocular problems, either as a result of HIV (human immune deficiency virus) itself or as a result of opportunistic infection. Some of these problems can lead to blindness if left untreated. Among the many pathogens that can lead to blindness, cytomegalovirus (CMV) is by far the most common. In FY 1994, we have evaluated the effectiveness of an intraocular delivery device in preventing the spread of CMV retinitis. We have now nearly completed recruitment for this study. Although no analysis has yet been done of the data, no significant adverse reaction has been noted, and in al cases progression of CMV retinitis has been prevented.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Intramural Research (Z01)
Project #
1Z01EY000218-01
Application #
3755557
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
U.S. National Eye Institute
Department
Type
DUNS #
City
State
Country
United States
Zip Code